Background: InRegen, with headquarters in the Cayman Islands, is a leader in three-dimensional regenerative medicine.
Cassel Salpeter:
Served as exclusive financial advisor to the Company in its divestiture of the Neo Urinary conduit assets
Ran a competitive sales process for the assets and assisted the Company in evaluating offers received
Assisted in the structuring, negotiating, and closing of the transaction
Challenges:
Complex technology
Small universe of potential buyers
Outcome: On December 31, 2018, InRegen closed on the sale of the Neo Urinary Conduit assets to Orgagen, Inc.
https://www.casselsalpeter.com/wp-content/uploads/2024/05/CS_Website-Case-Study-Logos_05.03.24_InRegen.jpg321385roaradminhttps://www.casselsalpeter.com/wp-content/uploads/2026/05/CasselSalpeter_15thExellence-1.pngroaradmin2018-12-01 17:02:532024-05-03 18:06:34inRegen sold certain assets to Orgagen
Background: Sancilio Pharmaceuticals Company, Inc. (“Sancilio”), based in Riviera Beach, FL, is an integrated specialty pharmaceutical company that develops, manufactures, and commercializes pharmaceutical products, over-the-counter and behind-the-counter products, and dietary supplements in the dental and women’s health markets.
Cassel Salpeter:
Served as financial advisor to the Company
Ran a competitive sales process, identifying and contacting over 300 strategic and financial parties
Provided assistance throughout all phases of the Chapter 11 Section 363 sales process, due diligence, and auction
Challenges:
Expedited sales timeline with less than six weeks to identify and solicit interest from potential bidders
Simultaneous, multiple sales processes for different divisions of the Company
Outcome: On August 1, 2018, the Ocean Blue division of Sancilio Pharmaceuticals Company, Inc. was purchased by K.D. Pharma Bexbach GmbH, headquartered in Bexbach, Germany.
https://www.casselsalpeter.com/wp-content/uploads/2024/05/CS_Website-Case-Study-Logos_05.03.24_SCI.jpg321385roaradminhttps://www.casselsalpeter.com/wp-content/uploads/2026/05/CasselSalpeter_15thExellence-1.pngroaradmin2018-08-02 17:28:312024-05-03 18:06:53Sancilio sold certain assets to K.D. Pharma Bexbach
Background: Sancilio Pharmaceuticals Company, Inc. (“Sancilio”), based in Riviera Beach, FL, is an integrated specialty pharmaceutical company that develops, manufactures, and commercializes pharmaceutical products, over-the-counter and behind-the-counter products, and dietary supplements in the dental and women’s health markets.
Cassel Salpeter:
Served as financial advisor to the Company
Ran a competitive sales process, identifying and contacting over 300 strategic and financial parties
Provided assistance throughout all phases of the Chapter 11 Section 363 sales process, due diligence, and auction
Challenges:
Expedited sales timeline with less than six weeks to identify and solicit interest from potential bidders
Simultaneous, multiple sales processes for different divisions of the Company
Outcome: On August 8, 2018, Altemia and the ALT Platform, a Phase III ready product for the treatment of sickle cell disease; a prenatal and dental portfolio of prenatal vitamins and fluorides; and the plant and labs of Sancilio Pharmaceuticals Company, Inc., were purchased by Micelle Biopharma, Inc.
https://www.casselsalpeter.com/wp-content/uploads/2024/05/CS_Website-Case-Study-Logos_05.03.24_SCI.jpg321385roaradminhttps://www.casselsalpeter.com/wp-content/uploads/2026/05/CasselSalpeter_15thExellence-1.pngroaradmin2018-08-02 17:25:072024-05-03 18:07:10Sancilio sold certain assets to Micelle Biopharma
Background: Convert IT Marketing, LLC (“Convert”), founded in 2011 and based in Ft. Lauderdale, FL, provides outsourced pay-per-click marketing solutions for local law firms in specialty practices throughout the U.S. Convert IT’s unique and proprietary strategies deliver superior performance to its 500+ customers in terms of cost and quality of leads, placing it in the top 1% of all digital marketers serving the legal vertical.
Cassel Salpeter:
Served as exclusive financial advisor to the Company in its divestiture of the Neo Urinary conduit assets
Ran a competitive sales process, identifying and contacting strategic and financial parties
Provided the owner with advice from pre-engagement to post-close
Challenges:
Limited buyer universe
Multiple offers ahead of the completion of initial calls
Outcome: On August 31, 2018, Convert IT was purchased by Abbey Road Capital.
https://www.casselsalpeter.com/wp-content/uploads/2024/05/CS_Website-Case-Study-Logos_05.03.24_ConvertIT.jpg321385roaradminhttps://www.casselsalpeter.com/wp-content/uploads/2026/05/CasselSalpeter_15thExellence-1.pngroaradmin2018-08-01 17:16:532024-05-03 18:07:26Convert has been acquired by Abbey Road Capital
Background: CORD:USE Cord Blood Bank (“Cord”), based in Orlando, FL, owns and operates a cord blood bank that focuses on building an inventory of umbilical cord blood stem cell units for patients in need of a life-saving transplant.
Cassel Salpeter:
Served as financial advisor to the Company
Advised Cord in evaluating its strategic options and provided assistance throughout the due diligence and closing process
Ran a broad sales process, contacting 115 parties
Challenges:
Small footprint – Marketing in select markets
Sizeable amount of debt
Complex capital structure
Outcome: In June 2018, Cord was acquired by Cryo-Cell International, Inc. The upfront consideration consisted of cash and shares of Common Stock with the potential for contingency cash payments based upon pre-determined milestones.
https://www.casselsalpeter.com/wp-content/uploads/2024/05/CS_Website-Case-Study-Logos_05.03.24_CORDUSE.jpg321385roaradminhttps://www.casselsalpeter.com/wp-content/uploads/2026/05/CasselSalpeter_15thExellence-1.pngroaradmin2018-06-01 17:29:412024-05-03 18:07:45CORD:USE has been acquired by Cryo-Cell International
